Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration.

ABSTRACT:

Purpose

To present the first pediatric study on the safety and efficacy of mastoid obliteration using S53P4 bioactive glass (BAG) for cholesteatoma surgery.

Methods

A single-center retrospective cohort study was conducted. Inclusion criteria were pediatric cases (≤ 18 years) and at least at least one year of follow-up including non-echo planar diffusion-weighted MRI to assess cholesteatoma recidivism. Both canal wall up (CWU) and canal wall down (CWD) procedures were evaluated.

Results

A total of 61 cases (56 patients) were included. Most cases had an otologic history before the development of the cholesteatoma. CWU procedure was performed in 18 cases (30%) and CWD procedure in 43 cases (70%). The cholesteatoma recidivism rate was 33% after a mean follow-up period of

SUBMITTER: Kroon VJ 

PROVIDER: S-EPMC9988747 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature